Search Results 51-60 of 17327 for prolia

  1. Phase I Study Of LB-100 With Docetaxel In Solid Tumors - Mayo Clinic

    LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of ...

  2. https://www.mayoclinic.org/spanish_organization_concepts.xml

  3. Drugs and Supplements that Start with V - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...

  4. Inclisiran (subcutaneous route) - Side effects & uses - Mayo Clinic

    Inclisiran injection is used together with a proper diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in patients with ...

  5. Creation of PLACENTA/Serum Repository Database: Autoimmunity from Mother To Baby Study - Mayo Clinic

    About this study. The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies.

  6. Anti-Lag-3 (Relatlimab) And Anti-PD-1 Blockade (Nivolumab) Versus Standard Of Care (Lomustine) For The Treatment Of Patients With Recurrent Glioblastoma - Mayo Clinic

    Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid (DNA) and may kill cancer ...

  7. A Study To Evaluate Belinostat And Guadecitabine Or ASTX727 To Treat Unresectable And Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  8. A Study Of Pomalidomide, Ixazomib Citrate, And Dexamethasone In Treating Patients With Previously Treated Multiple Myeloma Or Plasma Cell Leukemia - Mayo Clinic

    Biological therapies, such as pomalidomide, and dexamethasone, use substances made from living organisms that may stimulate or suppress the immune system in ...

  9. A Randomized, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of NIO752 In Participants With Progressive Supranuclear Palsy Followed By An Open Label Extension - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Participation eligibility.

  10. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The purpose of this study is to evaluate the safety and tolerability of the combination of DS-8201a in combination with olaparib, and to determine the ...